Nils Koch‐Henriksen

Clinical importance of neutralising antibodies against interferon beta in patients with relapsing-remitting multiple sclerosis

Per Soelberg Sørensen, Katja Maria Clemmesen, Klaus Bendtzen et al. · The Lancet · 2003 · 371 citations

Clinical Immunology, Relapsing-remitting Multiple Sclerosis, Autoimmune Disease +12

Demyelination versus remyelination in progressive multiple sclerosis

Stephan Bramow, Josa M. Frischer, Hans Lassmann et al. · Brain · 2010 · 300 citations

Childhood body mass index and multiple sclerosis risk: a long-term cohort study

Kassandra L. Munger, Joan Bentzen, Bjarne Laursen et al. · Multiple Sclerosis Journal · 2013 · 294 citations · Full text

Pain in Patients With Multiple Sclerosis

Kristina Bacher Svendsen, Troels S. Jensen, Kim Overvad et al. · Archives of Neurology · 2003 · 218 citations

Multiple Sclerosis After Infectious Mononucleosis

Trine Rasmussen Nielsen, Klaus Rostgaard, Nete Munk Nielsen et al. · Archives of Neurology · 2007 · 204 citations